secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2023-02-10T23:59:59+00:00
Accession:  0001493152-23-004279
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX Therapeutics amends convertible note with Juvenescence, adds $2M incremental borrowing capacity
--------------------------------------------------------------------------------

- AgeX may borrow up to an additional $2M from Juvenescence until May 9, 2023, subject to lender's discretion.
- Maximum single draw is $1M; total existing loan principal outstanding is $13.16M.
- Repayment date remains February 14, 2024; warrants equal to 50% of each advance granted to Juvenescence.
- Amended Note also reaffirms security interests and prior agreements including Warrant Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223004279/0001493152-23-004279-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223004279/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-004279

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer